bicalutamide and Carcinogenesis

bicalutamide has been researched along with Carcinogenesis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cai, S; Chen, H; Chen, K; Chen, R; Guo, S; Hu, Z; Ji, JY; Li, M; Li, W; Liu, J; Liu, X; Liu, Z; Wang, C; Wang, L; Wang, T; Wu, K; Wu, L; Xu, H; Xu, S; Yang, J; Ye, Z; Zhuang, Q	1

Other Studies

1 other study(ies) available for bicalutamide and Carcinogenesis

Article	Year
CAMK2N1 inhibits prostate cancer progression through androgen receptor-dependent signaling. Oncotarget, 2014, Nov-15, Volume: 5, Issue:21 Topics: Androgen Antagonists; Anilides; Antineoplastic Agents; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Carcinogenesis; Carcinoma; Cell Growth Processes; Drug Resistance; Feedback, Physiological; Gene Expression Regulation, Neoplastic; Humans; Male; Nitriles; Oncogene Protein v-akt; Prostatic Neoplasms; Proteins; Receptors, Androgen; RNA, Small Interfering; Signal Transduction; Survival Analysis; Tosyl Compounds; Tumor Cells, Cultured	2014

Article

Year

CAMK2N1 inhibits prostate cancer progression through androgen receptor-dependent signaling.

Oncotarget, 2014, Nov-15, Volume: 5, Issue:21

Topics: Androgen Antagonists; Anilides; Antineoplastic Agents; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Carcinogenesis; Carcinoma; Cell Growth Processes; Drug Resistance; Feedback, Physiological; Gene Expression Regulation, Neoplastic; Humans; Male; Nitriles; Oncogene Protein v-akt; Prostatic Neoplasms; Proteins; Receptors, Androgen; RNA, Small Interfering; Signal Transduction; Survival Analysis; Tosyl Compounds; Tumor Cells, Cultured

2014